148 related articles for article (PubMed ID: 35535347)
1. NEIL3 Mediates Lung Cancer Progression and Modulates PI3K/AKT/mTOR Signaling: A Potential Therapeutic Target.
Huang H; Hua Q
Int J Genomics; 2022; 2022():8348499. PubMed ID: 35535347
[TBL] [Abstract][Full Text] [Related]
2. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
[TBL] [Abstract][Full Text] [Related]
3.
Wang W; Yin Q; Guo S; Wang J
Exp Ther Med; 2021 Oct; 22(4):1053. PubMed ID: 34434267
[TBL] [Abstract][Full Text] [Related]
4. NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma.
Zhao C; Liu J; Zhou H; Qian X; Sun H; Chen X; Zheng M; Bian T; Liu L; Liu Y; Zhang J
Cancer Cell Int; 2021 Apr; 21(1):228. PubMed ID: 33879165
[TBL] [Abstract][Full Text] [Related]
5. CYP26A1 Is a Novel Cancer Biomarker of Pancreatic Carcinoma: Evidence from Integration Analysis and
Yu Y; Wang Y; Zou Y; Yu Y
Dis Markers; 2022; 2022():5286820. PubMed ID: 35707714
[TBL] [Abstract][Full Text] [Related]
6. Effect of BRAF-mediated PI3K/Akt/mTOR pathway on biological characteristics and chemosensitivity of NSCLC A549/DDP cells.
Ren B; Liu H; Yang Y; Lian Y
Oncol Lett; 2021 Aug; 22(2):584. PubMed ID: 34122635
[TBL] [Abstract][Full Text] [Related]
7. Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway.
Fan S; Yan S; Yang Y; Shang J; Hao M
Onco Targets Ther; 2021; 14():2463-2473. PubMed ID: 33883901
[TBL] [Abstract][Full Text] [Related]
8. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway.
Shi H; Pu J; Zhou XL; Ning YY; Bai C
Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375
[TBL] [Abstract][Full Text] [Related]
9. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression.
Xia A; Li H; Li R; Lu L; Wu X
Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the lncRNA AC012213.3 Promotes Proliferation, Migration and Invasion of Breast Cancer via RAD54B/PI3K/AKT Axis and is Associated with Worse Patient Prognosis.
Zhong H; Zeng G; He L
Cancer Manag Res; 2021; 13():7213-7223. PubMed ID: 34557038
[TBL] [Abstract][Full Text] [Related]
11. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
12. Glycogen phosphorylase B promotes cell proliferation and migration through PI3K/AKT pathway in non-small cell lung cancer.
Zhan Y; Chen R; Wang T; Shan S; Zhu H
Exp Lung Res; 2021 Apr; 47(3):111-120. PubMed ID: 33336613
[TBL] [Abstract][Full Text] [Related]
13. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT/mTOR signaling pathway in non-small cell lung cancer.
Li J; Cheng D; Zhu M; Yu H; Pan Z; Liu L; Geng Q; Pan H; Yan M; Yao M
Theranostics; 2019; 9(1):179-195. PubMed ID: 30662561
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA-JPX predicts the poor prognosis of ovarian cancer patients and promotes tumor cell proliferation, invasion and migration by the PI3K/Akt/mTOR signaling pathway.
Li J; Feng L; Tian C; Tang YL; Tang Y; Hu FQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8135-8144. PubMed ID: 30556851
[TBL] [Abstract][Full Text] [Related]
16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
17. Autocrined leptin promotes proliferation of non-small cell lung cancer (NSCLC) via
Wang J; Zhou F; Li F; Wang B; Hu Y; Li X
Ann Transl Med; 2021 Apr; 9(7):568. PubMed ID: 33987266
[TBL] [Abstract][Full Text] [Related]
18. Transcription Factor MAZ Potentiates the Upregulated NEIL3-mediated Aerobic Glycolysis, Thereby Promoting Angiogenesis in Hepatocellular Carcinoma.
Zhang F; Wang B; Zhang W; Xu Y; Zhang C; Xue X
Curr Cancer Drug Targets; 2024 Feb; ():. PubMed ID: 38347781
[TBL] [Abstract][Full Text] [Related]
19. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
[TBL] [Abstract][Full Text] [Related]
20. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
Liao H; Zhang L; Lu S; Li W; Dong W
Front Genet; 2022; 13():848926. PubMed ID: 35812733
[No Abstract] [Full Text] [Related]
[Next] [New Search]